Alkermes plc (ALKS)
NASDAQ·Healthcare·Biotechnology
$50.71
-3.82%
Mkt Cap $8.79B
Analyst Ratings
Buy
16
Hold
2
Sell
1
Price Target (28 analysts)
$52.60
Range $43.00 – $65.00
Implied Upside
+3.7%
Consensus $52.60 vs current $50.71
NASDAQ·Healthcare·Biotechnology
$50.71
-3.82%
Mkt Cap $8.79B
Buy
16
Hold
2
Sell
1
Price Target (28 analysts)
$52.60
Range $43.00 – $65.00
+3.7%
Consensus $52.60 vs current $50.71